Published in Agents Actions on August 01, 1987
Antinociceptive and anti-inflammatory activities of Bridelia retusa methanolic fruit extract in experimental animals. ScientificWorldJournal (2014) 0.83
Evaluation of anti-inflammatory and antinociceptive activity of Triphala recipe. Afr J Tradit Complement Altern Med (2012) 0.80
A possible anti-inflammatory mechanism of ethyl acetate extracts of Teucrium stocksianum Bioss. BMC Complement Altern Med (2015) 0.78
Evaluation of anti-inflammatory, analgesic, and antipyretic activities of the ethanol extract from Murdannia loriformis (Hassk.) Rolla Rao et Kammathy. Bioimpacts (2014) 0.75
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst (1984) 2.08
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol (1981) 1.58
Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst (1980) 1.49
Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli. J Natl Cancer Inst (1995) 1.47
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans (1997) 1.45
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm (1997) 1.40
Delayed recognition of podophyllum toxicity in a patient receiving epidural morphine. Anesth Analg (1990) 1.40
Sr lattice clock at 1 x 10(-16) fractional uncertainty by remote optical evaluation with a Ca clock. Science (2008) 1.34
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys (2000) 1.32
Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer (1980) 1.31
Driving phase slips in a superfluid atom circuit with a rotating weak link. Phys Rev Lett (2013) 1.28
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet (2009) 1.28
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol (1984) 1.25
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
Superflow in a toroidal Bose-Einstein condensate: an atom circuit with a tunable weak link. Phys Rev Lett (2011) 1.17
Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev (1982) 1.15
Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALB/c mice. Cell Immunol (1978) 1.09
Role of natural killer cells in host defense against cancer metastasis. Symp Fundam Cancer Res (1983) 1.08
New limits on coupling of fundamental constants to gravity using 87Sr optical lattice clocks. Phys Rev Lett (2008) 1.06
Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice. Cancer Res (1981) 1.06
Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. J Immunol (1983) 1.06
Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridisation. Genitourin Med (1988) 1.05
"Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology (N Y) (1992) 1.04
Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. J Immunol (1986) 1.04
Effects of prostaglandins and cAMP levels on monocyte IL-1 production. Agents Actions (1989) 1.03
Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res (2007) 1.03
Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression. Arthritis Rheum (1986) 1.02
The role of natural killer cells in the control of tumor growth and metastasis. Biochim Biophys Acta (1985) 1.02
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. Ann Oncol (2007) 1.02
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrob Agents Chemother (1997) 1.01
CD3-associated heterodimeric polypeptides on suppressor hybridomas define biologically active inhibitory cells. Proc Natl Acad Sci U S A (1988) 1.00
SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochem Pharmacol (1987) 0.99
Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus (2006) 0.99
Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein. Immunology (1975) 0.98
Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells. Immunology (1978) 0.98
The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet (2011) 0.98
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol (2013) 0.97
Structural requirements for in vivo and in vitro immunogenicity in hapten-specific delayed hypersensitivity. Cell Immunol (1973) 0.96
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma. Int J Oncol (1999) 0.95
Macrophage activation in rat models of inflammation and arthritis: determination of markers of stages of activation. Cell Immunol (1986) 0.95
Normal immunosuppressive protein inhibition of human and murine lymphoblastoid cell line proliferation. Eur J Immunol (1979) 0.95
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees. Clin Immunol (2001) 0.94
Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine (1992) 0.94
Normal immunosuppressive protein purification and quantitative estimation experiments. J Immunol Methods (1979) 0.93
A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation. J Immunol (1998) 0.93
Cooperative effects in antibody formation produced by hapten-specific delayed sensitivity. J Immunol (1973) 0.92
Solution structure of human plasma fibronectin under different solvent conditions. Fluorescence energy transfer, circular dichroism and light-scattering studies. J Mol Biol (1993) 0.91
Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheum (1988) 0.91
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet (2013) 0.90
Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci U S A (1992) 0.90
Rhodobacter sphaeroides phosphoribulokinase: binary and ternary complexes with nucleotide substrate analogs and effectors. Biochemistry (1996) 0.90
Evaluation of the Phadebact ETEC-LT test for the heat-labile enterotoxin of Escherichia coli. Zentralbl Bakteriol (1989) 0.89
Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int J Immunopharmacol (1988) 0.89
Effect of Normal Immunosuppressive Protein (NIP) on tumor growth in mice. Eur J Cancer (1975) 0.88
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol (2005) 0.88
Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res (1982) 0.87
Role of normal immunosuppressive protein (NIP) in immunologic surveillance. Transplant Proc (1977) 0.87
Labor-associated changes in Fas ligand expression and function in human placenta. Pediatr Res (2000) 0.86
Effect of antiarthritic drugs on the enhanced interleukin-1 (IL-1) production by macrophages from adjuvant-induced arthritic (AA) rats. Agents Actions (1987) 0.86
Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models for experimental metastasis. Int J Cancer (1982) 0.86
Polybrominated diphenyl ethers enhance the production of proinflammatory cytokines by the placenta. Placenta (2012) 0.86
A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4. Clin Immunol Immunopathol (1997) 0.86
Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a. Biochem Pharmacol (1990) 0.86
Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol (1988) 0.86
Novel diversity in IL-4-mediated responses in resting human naive B cells versus germinal center/memory B cells. J Immunol (2000) 0.85
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. Hum Gene Ther (2001) 0.85
In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. J Natl Cancer Inst (1981) 0.85
Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice. Antimicrob Agents Chemother (1997) 0.85
Thrombocyte specific antigens. Detection of organ specific antigens by heterospecific anti-thrombocyte serum. Immunology (1969) 0.85
Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action. Circ Shock (1989) 0.85
Fetal cardiac output in the isoimmunized pregnancy: a pulsed Doppler-echocardiographic study of patients undergoing intravascular intrauterine transfusion. Am J Obstet Gynecol (1989) 0.83
Detection of human papillomavirus DNA in the urogenital tracts of men with anogenital warts. Sex Transm Dis (1993) 0.83
Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University. Ann Oncol (2005) 0.82
Quantitative Western blot assay for measurement of the murine acute phase reactant, serum amyloid P component. J Immunol Methods (1986) 0.82
Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres. Drug Alcohol Depend (2007) 0.82
Activation of the IL-1 gene in UV-irradiated mouse skin: association with inflammatory sequelae and pharmacologic intervention. J Invest Dermatol (1991) 0.81
Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin. J Rheumatol (1985) 0.81
Hypothermic ischemic arrest versus hypothermic potassium cardioplegia in human beings. Ann Thorac Surg (1982) 0.80
Adjuvant-induced nonspecific supressor cells: in vitro and in vivo studies. Cell Immunol (1980) 0.80
Augmentation of human natural killer cell activity by influenza virus antigens produced in Escherichia coli. J Biol Response Mod (1987) 0.80
Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002. Inflammation (1987) 0.80
Comparison of Cuban and Anglo-American cultural values in a clinical population. J Consult Clin Psychol (1979) 0.79
Synergistic action of antibodies. II. Interferance of heteroantibodies with cell agglutination by isoantibodies. Vox Sang (1968) 0.78
Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase. Agents Actions (1987) 0.78
Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation. Cancer Res (1990) 0.78
In vivo models for studies of human tumor metastasis. Prog Clin Biol Res (1982) 0.78
In vitro correlates of hapten-specific delayed hypersensitivity. Cell Immunol (1973) 0.78
Altered immunogenicity produced by change in mode of linkage of hapten to carrier. Proc Soc Exp Biol Med (1972) 0.78
Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents. J Med Chem (1990) 0.78
Inflammation and recruitment of immune cells into the lung. Reg Immunol (1990) 0.78
Free and membrane-bound ribosomes. I. Separation by two-dimensional gel electrophoresis of proteins from rat liver monosomes. Biochim Biophys Acta (1973) 0.78
Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. J Autoimmun (1990) 0.78
The anti-inflammatory effect of heterologous anti-polymorphonuclear leucocyte serum on adjuvant-induced arthritis. Proc Soc Exp Biol Med (1974) 0.77